跳至主要内容
临床试验/NCT01121653
NCT01121653已完成4 期

Impact of Oral Magnesium on Neuropathic Pain

University Hospital, Clermont-Ferrand2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2006年3月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
50
试验地点
2
主要终点
Pain scores (neuropathic pain evaluation questionnaire)

研究概览

简要总结

Use lay language.

The aim of this study is to evaluate on pain scores (neuropathic pain questionnaire and pain numeric scale) and on quality of life, the effect of oral magnesium intake on patients with neuropathic pain comparing with patients receiving placebo,. The study drug will be taken during 4 weeks.

详细描述

Protocol description

Visit D0

  • patient inclusion after informed signed consent
  • clinical exam
  • blood sampling (magnesium dosage)
  • questionnaires (neuropathic pain and quality of life)
  • daily self-evaluation on neuropathic pain scale (Week0 to Week5)

D8 : first intake of study drug (magnesium or placebo)

Visit Week5:

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - neuropathic pain
  • - informed signed consent

排除标准

  • magnesium intake contra-indication
  • severe renal insufficiency
  • quinidine intake
  • concomitant treatment change 2weeks before inclusion
  • evolutive pathology

结局指标

主要结局

Pain scores (neuropathic pain evaluation questionnaire)

时间窗: Visit D0

次要结局

  • - Numeric scale - quality o f life questionnaires(Visit Week 5)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other

研究点 (2)

Loading locations...

相似试验